GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $61,690,000 | -1.0% | 1,417,176 | -0.9% | 0.08% | +18.8% |
| Q1 2022 | $62,322,000 | +0.1% | 1,430,715 | +1.4% | 0.06% | +4.9% |
| Q4 2021 | $62,233,000 | +7.1% | 1,411,180 | -7.2% | 0.06% | -1.6% |
| Q3 2021 | $58,104,000 | -1.3% | 1,520,641 | +2.9% | 0.06% | -3.1% |
| Q2 2021 | $58,865,000 | +4.1% | 1,478,273 | -6.7% | 0.06% | -5.9% |
| Q1 2021 | $56,570,000 | +3.5% | 1,585,042 | +6.7% | 0.07% | -5.6% |
| Q4 2020 | $54,657,000 | +5.7% | 1,485,235 | +8.1% | 0.07% | -13.3% |
| Q3 2020 | $51,723,000 | +11.8% | 1,374,154 | +21.2% | 0.08% | +3.8% |
| Q2 2020 | $46,263,000 | +14.6% | 1,134,175 | +6.4% | 0.08% | -12.1% |
| Q1 2020 | $40,375,000 | -16.9% | 1,065,583 | +3.0% | 0.09% | +9.6% |
| Q4 2019 | $48,590,000 | +17.4% | 1,034,047 | +6.6% | 0.08% | +6.4% |
| Q3 2019 | $41,383,000 | +24.1% | 969,600 | +16.4% | 0.08% | +23.8% |
| Q2 2019 | $33,339,000 | +11.6% | 833,054 | +16.6% | 0.06% | +6.8% |
| Q1 2019 | $29,864,000 | +25.3% | 714,614 | +14.6% | 0.06% | +3.5% |
| Q4 2018 | $23,831,000 | +0.4% | 623,686 | +5.5% | 0.06% | +29.5% |
| Q3 2018 | $23,746,000 | +10.1% | 591,131 | +10.4% | 0.04% | -2.2% |
| Q2 2018 | $21,575,000 | -0.7% | 535,232 | -3.7% | 0.04% | -10.0% |
| Q1 2018 | $21,721,000 | -1.2% | 555,961 | -10.3% | 0.05% | -3.8% |
| Q4 2017 | $21,974,000 | +10.2% | 619,519 | +26.1% | 0.05% | +2.0% |
| Q3 2017 | $19,948,000 | +2.2% | 491,331 | +8.6% | 0.05% | -1.9% |
| Q2 2017 | $19,513,000 | +5.6% | 452,533 | +3.2% | 0.05% | +2.0% |
| Q1 2017 | $18,478,000 | +18.7% | 438,293 | +8.4% | 0.05% | +10.9% |
| Q4 2016 | $15,572,000 | +10.2% | 404,350 | +23.5% | 0.05% | +9.5% |
| Q3 2016 | $14,125,000 | +17.2% | 327,491 | +17.7% | 0.04% | +10.5% |
| Q2 2016 | $12,055,000 | +27.9% | 278,140 | +19.6% | 0.04% | +26.7% |
| Q1 2016 | $9,429,000 | +27.3% | 232,535 | +26.7% | 0.03% | +57.9% |
| Q4 2015 | $7,407,000 | +20.1% | 183,577 | +14.4% | 0.02% | +5.6% |
| Q3 2015 | $6,168,000 | -13.1% | 160,420 | -5.9% | 0.02% | 0.0% |
| Q2 2015 | $7,099,000 | +10.1% | 170,456 | +22.0% | 0.02% | -5.3% |
| Q1 2015 | $6,445,000 | +4.4% | 139,664 | -3.4% | 0.02% | -9.5% |
| Q4 2014 | $6,176,000 | +17.7% | 144,510 | +26.6% | 0.02% | 0.0% |
| Q3 2014 | $5,249,000 | +6.6% | 114,190 | +24.0% | 0.02% | +5.0% |
| Q2 2014 | $4,925,000 | -8.3% | 92,096 | -8.4% | 0.02% | -16.7% |
| Q1 2014 | $5,370,000 | -0.7% | 100,498 | -0.8% | 0.02% | -7.7% |
| Q4 2013 | $5,410,000 | +10.0% | 101,324 | +3.4% | 0.03% | -3.7% |
| Q3 2013 | $4,917,000 | +7.4% | 98,006 | +6.9% | 0.03% | -10.0% |
| Q2 2013 | $4,580,000 | – | 91,656 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |